Sharpless Reaffirms FDA Focus On Competition, E-Cigs, Supplements

Newly minted FDA Acting Commissioner Ned Sharpless said he will not stray far from FDA’s current goals, especially those that were laid out under former commissioner Scott Gottlieb’s leadership. In his first all-hands speech at FDA on Tuesday (April 16), Sharpless said the agency will continue its work to increase competition and bring down drug costs, regulate e-cigarettes and other tobacco products, reform dietary supplement oversight, and advance use of real-world evidence for novel medical devices. He added he is...